Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
WADA 2026 Prohibited List Status (Section S0) Retatrutide is not currently named explicitly on the World Anti-Doping Agency 2025 or 2026 Prohibited Lists but falls within section S0 (Non-Approved Substances), which covers any pharmacological substance not currently approved by a governmental health authority for human therapeutic use
Gastrointestinal issues (nausea, vomiting, diarrhea or constipation) are the most common, while rare but serious side effects such as pancreatitis or gallbladder disease can occur
Start your intake Understanding GLP-1 Availability in Canada GLP-1 receptor agonists in Canada include both brand-name medications (typically prescribed through healthcare providers) and compounded formulations (sourced from licensed 503A compounding pharmacies)
B5 (Pantothenic Acid) Pantothenic acid is vital for the production of certain hormones and neurotransmitters
US$ 22.44
US$ 22.86
US$ 25.84
US$ 28.19
US$ 25.56
US$ 23.37
US$ 28.17
US$ 26.98
US$ 21.76
US$ 20.55
